| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 07/17/2002 | EP1222182A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 07/17/2002 | EP0828494B1 Method for treating cognitive dysfunction |
| 07/17/2002 | CN1359377A Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 07/17/2002 | CN1358725A Process for preparing (3aS, 6aR)-1,3-dibenzyl-tetrahydro-4H-thiophenebin [3,4-d] imidazolium-2,4-(1H)-diketone |
| 07/16/2002 | US6420417 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
| 07/16/2002 | US6420391 Fused thiophone derivatives and drugs containing the same as the active ingredient |
| 07/16/2002 | US6420383 Calcium channel blockers, hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders. |
| 07/16/2002 | US6420368 Thienopyrimidines |
| 07/16/2002 | US6420363 Mono- or polyenic carboxylic acid derivatives |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2001040187A3 Compound having effect of promoting neuron differentiation |
| 07/11/2002 | US20020091134 Novel 4-phenyl substituted tetrahydroiso quinolines therapeutic use thereof |
| 07/10/2002 | CN1358186A Tricyclic benzoylcylohexanedione derivatives |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/04/2002 | WO2002051849A1 Cdk4 inhibitors |
| 07/04/2002 | WO2002051848A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 07/04/2002 | WO2002051418A1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 07/04/2002 | US20020086993 Crystal modification |
| 07/04/2002 | US20020084446 Hyperpolarizable organic chromophores |
| 07/04/2002 | DE10064994A1 Sulfamidothienopyrimidine Sulfamidothienopyrimidine |
| 07/04/2002 | DE10063992A1 Tryptophan-Analoga in Proteinen, Peptiden und peptidischen Leitstrukturen Tryptophan analogues into proteins, peptides and peptide lead structures |
| 07/03/2002 | EP1219603A2 Tryptophan analogs in proteins, peptides and peptidic structures |
| 07/03/2002 | EP1218374A1 Pharmaceutically active sulfonamide derivatives |
| 07/03/2002 | EP1218361A1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 07/03/2002 | EP1218353A1 Quinazoline derivatives |
| 07/03/2002 | CN1356981A Pharmaceutical compounds |
| 07/02/2002 | US6414013 Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| 07/02/2002 | US6414002 Antilipemic agents; anticancer, antitumor agents |
| 07/02/2002 | US6413960 Substituted pyrazolyl benzenesulfonamides for the treatment of asthma |
| 07/02/2002 | US6413724 Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones |
| 07/02/2002 | CA2022119C Substituted aromatic sulfonamides as antiglaucoma agents |
| 06/27/2002 | WO2002050082A2 Inhibitors of papilloma virus |
| 06/27/2002 | WO2002050080A1 Small molecules useful in the treatment of inflammatory disease |
| 06/27/2002 | WO2002050066A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002050065A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002050029A2 Tetracyclic derivatives as spla2 inhibitors |
| 06/27/2002 | WO2002049649A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 06/27/2002 | WO2002022602A3 Triazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2001092267A3 Dihydropyridine compounds for the inhibition of calcium-influx |
| 06/27/2002 | US20020082256 Compounds useful as anti-inflammatory agents |
| 06/27/2002 | US20020082251 Desmethylolanzapine compositions and methods |
| 06/27/2002 | CA2431721A1 Tetracyclic derivatives as spla2 inhibitors |
| 06/27/2002 | CA2431147A1 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 06/26/2002 | EP1216250A1 Thienoisoxazolyl and thienylpyrrazolyl phenoxy substituted propyl derivatives useful as d4 antagonists |
| 06/26/2002 | EP0865486A4 Stable biotinylated biomolecule composition and methods |
| 06/26/2002 | CN1355805A Thienopyrimidines compound |
| 06/25/2002 | US6410747 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias |
| 06/25/2002 | US6410586 Modulators of protein tyrosine phosphatases (PTPases) |
| 06/25/2002 | US6410566 Cyclic amine derivatives and their use as drugs |
| 06/25/2002 | US6410556 Antidiabetic agents |
| 06/25/2002 | US6410553 Benzosulfones and related compositions and methods |
| 06/25/2002 | US6410541 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives administered as antitumor agents |
| 06/25/2002 | US6410540 Inhibitors of p38-αkinase |
| 06/20/2002 | WO2002048150A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
| 06/20/2002 | WO2002048112A2 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 06/20/2002 | WO2002047762A1 Serine protease inhibitors |
| 06/20/2002 | WO2002047722A1 Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof |
| 06/20/2002 | WO2002018357A8 A ONE-POT PROCESS FOR THE PREPARATION OF PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS OF 4, 5, 6, 7 - TETRAHYDROTHIENO (3,2-c) PYRIDINE DERIVATIVES HAVING ANTITHROMBOTIC ACTIVITY |
| 06/20/2002 | WO2002004455A3 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 06/20/2002 | US20020077486 Platelet ADP receptor inhibitors |
| 06/20/2002 | US20020077474 Heterocyclic amino substituted heteroaryl fused pyridines; GABA brain receptor ligands |
| 06/20/2002 | US20020077338 HIV protease inhibitors |
| 06/20/2002 | US20020077337 Chemical compounds |
| 06/19/2002 | EP1214325A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214324A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214317A1 Antiviral agents |
| 06/19/2002 | EP1214060A2 Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48 |
| 06/19/2002 | EP1196199A4 Water soluble multi-biotin-containing compounds |
| 06/19/2002 | CN1354740A Pharmaceutical compounds |
| 06/18/2002 | US6407116 2,4-dioxo-1,2,3,4-tetrahydroquinazoline derivatives; antiallergens, antiasthmatics, antihistamines, and antiinflammatory agents |
| 06/18/2002 | US6407115 Anticarcinogenic and antitumor agents; side effect reduction, water solubility |
| 06/18/2002 | US6407112 2a,3,4,5-tetrahydro-1h-benz(cd)indol-2-one derivatives; 5-hydroxytryptamine agonists; sleep, circadian rhythym, bipolar, and psychological disorder treatment |
| 06/18/2002 | CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
| 06/13/2002 | WO2002046166A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 06/13/2002 | WO2002000657A3 Condensed pyrazindione derivatives |
| 06/13/2002 | US20020072617 As pesticides and herbicides |
| 06/13/2002 | US20020072515 For therapy and prophylaxis of ischemic heart diseases such as angina pectoris, arrhythmia, myocardial infarction, congestive heart failure, cerebral infarction and cerebral sequelae after subarachnoid hemorrhage, hypertension |
| 06/12/2002 | EP1213291A1 Spiro [1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine for use in the treatment of psychotic and intellectual impairment disorders |
| 06/12/2002 | EP1212329A2 Amine derivatives of benzo[4,5]thieno[2,3-d]pyrimidine |
| 06/12/2002 | EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/12/2002 | EP1212062A1 Use of thienopyrimidines |
| 06/12/2002 | EP0873320B1 Piperazine derivatives as tachykinin antagonists |
| 06/12/2002 | EP0775146B1 Novel process for the preparation of diisopinocampheylchloroborane |
| 06/12/2002 | EP0640605B1 Spiropyran compound, optically active spiropyran compound, and use thereof |
| 06/12/2002 | EP0639269B1 Ionic reservoir at electrode surface |
| 06/12/2002 | CN1353716A benzopyrans annelated in C7-C8 with an aromatic heterocycle and compositions and (co) polymer matrices containing them |
| 06/11/2002 | US6403809 Compounds for electronic devices |
| 06/11/2002 | US6403606 Antiinflammatory, antiarthritis, a drug for inhibiting bone resorption, immunosuppressant |
| 06/11/2002 | US6403583 Anticoagulant agents for treatment and prevention of thromboembolic disorders. |
| 06/11/2002 | CA2239705C Quinazoline-4-one ampa antagonists |
| 06/06/2002 | WO2002044183A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 06/06/2002 | WO2002043766A1 Medicinal compositions and process for producing the same |
| 06/06/2002 | WO2002012198A3 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 06/06/2002 | WO2001077668A3 Proteomic analysis using active-site directed probes |
| 06/06/2002 | US20020068705 Sugar derivatives of indolocarbazoles; exhibit topoisomerase-I activity |
| 06/05/2002 | EP1210084A1 Pyridomorphinans, thienomoprhinans and use thereof |
| 06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
| 06/04/2002 | US6399638 Anticarcinogenic agents; microtubule stabilizing effects |
| 06/04/2002 | US6399616 4-(4-(2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl)ethyl)-1 -piperazinyl)furo(3,2-c)pyridine; combined serotonin reuptake inhibitor and partial agonist of 5-ht receptors; reduced latency; depression |
| 06/04/2002 | US6399601 Antidiabetic agents; nervous system disorders; anticholesterol agents |